JP2013512454A5 - - Google Patents

Download PDF

Info

Publication number
JP2013512454A5
JP2013512454A5 JP2012542115A JP2012542115A JP2013512454A5 JP 2013512454 A5 JP2013512454 A5 JP 2013512454A5 JP 2012542115 A JP2012542115 A JP 2012542115A JP 2012542115 A JP2012542115 A JP 2012542115A JP 2013512454 A5 JP2013512454 A5 JP 2013512454A5
Authority
JP
Japan
Prior art keywords
concentration
cea
protein
cea protein
full
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012542115A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013512454A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/058206 external-priority patent/WO2011068758A1/en
Publication of JP2013512454A publication Critical patent/JP2013512454A/ja
Publication of JP2013512454A5 publication Critical patent/JP2013512454A5/ja
Pending legal-status Critical Current

Links

JP2012542115A 2009-12-01 2010-11-29 Ceaを発現する癌を検出および治療するための改善された方法および組成物 Pending JP2013512454A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26558009P 2009-12-01 2009-12-01
US61/265,580 2009-12-01
PCT/US2010/058206 WO2011068758A1 (en) 2009-12-01 2010-11-29 Improved methods and compositions for detecting and treating cea-expressing cancers

Publications (2)

Publication Number Publication Date
JP2013512454A JP2013512454A (ja) 2013-04-11
JP2013512454A5 true JP2013512454A5 (https=) 2014-01-23

Family

ID=44115238

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012542115A Pending JP2013512454A (ja) 2009-12-01 2010-11-29 Ceaを発現する癌を検出および治療するための改善された方法および組成物

Country Status (6)

Country Link
US (1) US20130035249A1 (https=)
EP (1) EP2507628A4 (https=)
JP (1) JP2013512454A (https=)
AU (1) AU2010326174A1 (https=)
CA (1) CA2782330A1 (https=)
WO (1) WO2011068758A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140242081A1 (en) * 2011-07-18 2014-08-28 Micromet Ag Dosing regimens for treatment of cea-expressing cancers
JP2014161283A (ja) * 2013-02-26 2014-09-08 Shizuoka Prefecture Ceacam5遺伝子のスプライシングバリアント
EP3145531A4 (en) * 2014-05-02 2018-03-21 Icahn School of Medicine at Mount Sinai Ceacam5 peptides for crohn's disease
WO2016036678A1 (en) * 2014-09-02 2016-03-10 Medimmune, Llc Formulations of bispecific antibodies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9324807D0 (en) * 1993-12-03 1994-01-19 Cancer Res Campaign Tech Tumour antibody
JP2001002700A (ja) * 1999-06-18 2001-01-09 Wako Pure Chem Ind Ltd 癌の判定方法
AU3655301A (en) * 2000-01-25 2001-08-07 Nuvelo, Inc. Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
WO2002040059A2 (en) * 2000-11-01 2002-05-23 American Foundation For Biological Research, Inc. Methods and compositions for inducing cell-mediated immune responses
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
ATE520979T1 (de) * 2005-08-24 2011-09-15 Bristol Myers Squibb Co Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors
LT1976880T (lt) * 2005-12-21 2016-10-10 Amgen Research (Munich) Gmbh Farmacinės kompozicijos, pasižyminčios atsparumu tirpiam cea

Similar Documents

Publication Publication Date Title
JP2016026303A5 (https=)
JP2015533788A5 (https=)
EP3885768A1 (en) Biomarker panel for diagnosing cancer
JP2017518366A5 (https=)
JP2018511319A5 (https=)
JP2009001563A5 (https=)
JP2015516985A5 (https=)
JP2006520781A5 (https=)
JP2009195240A5 (https=)
JP2014503180A5 (https=)
JP2015527365A5 (https=)
JP2018505681A5 (https=)
JP2012505659A5 (https=)
JP2013512454A5 (https=)
US20080026394A1 (en) Methods of detecting one or more cancer markers
JP2019529346A5 (https=)
JP2022023168A (ja) 免疫チェックポイント阻害剤pd-1及びpd-l1に対する抗体治療をモニタリングするためのイムノアッセイ及び操作されたタンパク質
JPWO2021247540A5 (https=)
KR20190013707A (ko) 암 검출을 위한 뉴클레오솜-전사 인자 복합체의 용도
JP2013503644A5 (https=)
CN107110848B (zh) 以脱氧羟腐胺缩赖氨酸合酶基因作为指标使用的动脉硬化及癌的检测方法
Kim et al. A one-step immunoassay based on switching peptides for diagnosis of porcine epidemic diarrhea virus (PEDV) using screened Fv-antibodies
JP5821198B2 (ja) 抗il28b抗体及びこれを用いたil28bの測定方法
Wu et al. Development of a highly sensitive C1QC-targeting aptamer and its application in a modified antibody-aptamer sandwich biosensor for C1QC biomarker detection
JP2008535855A5 (https=)